Predictors of treatment response in a lupus nephritis population: lessons from the Aspreva Lupus Management Study (ALMS) trial

MASTERPLANS Consortium

Research output: Contribution to journalArticlepeer-review

13 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Predictors of treatment response in a lupus nephritis population: lessons from the Aspreva Lupus Management Study (ALMS) trial'. Together they form a unique fingerprint.

Medicine & Life Sciences